Michael Straughen - 01 Apr 2022 Form 4 Insider Report for CORE LABORATORIES N V

Role
Director
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Apr 2022
Net transactions value
-$64,276
Form type
4
Filing time
04 Apr 2022, 17:05:43 UTC
Next filing
03 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Tax liability $64,276 -1,982 -13% $32.43* 13,506 01 Apr 2022 Direct
transaction CLB Common Shares Options Exercise $0 +4,307 +39% $0.000000 15,488 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Restricted Shares Award $0 +5,485 $0.000000 5,485 01 Apr 2022 Common Shares 5,485 $0.000000 Direct F1
transaction CLB Restricted Shares Options Exercise $0 -4,307 -100% $0.000000* 0 01 Apr 2022 Common Shares 4,307 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2023, subject to the terms of issuance.
F2 The Restricted Shares vested at the end of a one-year vesting period on April 1, 2022.